Sun Pharma Q3 results show strong US sales performance
pre-market1 source ↓written by the desknot a recommendation
- YoY
- 16% increase
- formulation sales reached
- $477 million
- to total sales
- 27.5%
- to ₹15
- 13.5%
Sun Pharmaceutical Industries Ltd reported Q3 net profit ₹3,368.8 cr, a 16% increase YoY, surpassing estimates. US formulation sales reached $477 million, contributing 27.5% to total sales. Revenue rose 13.5% to ₹15,520.5 cr, indicating robust operational performance. This positive outcome may boost investor sentiment in the pharma sector.
Not investment advice. For informational purposes only.